ArticleJournal for immunotherapy of cancer2023

Tumor cell-intrinsic SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway.

Xufen Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.